{
    "code": "01014755",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01014755",
    "time": "2022-07-15 06:53:33",
    "許可證字號": "衛署藥製字第014755號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/05\/25",
    "發證日期": "67\/05\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00101475503",
    "中文品名": "双克痛錠",
    "英文品名": "DIKUTON TABLETS",
    "適應症": "頭痛、齒痛、肌肉酸痛、扭傷痛、月經痛之鎮痛",
    "劑型": "110錠劑",
    "包裝": "盒裝 瓶裝 罐裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ORPHENADRINE CITRATE, ACETAMINOPHEN (EQ TO PARACETAMOL)",
    "限制項目": "09委託製造",
    "申請商名稱": "1304820200  瑞士藥廠股份有限公司",
    "申請商地址": "台南市新市區中山路182號",
    "主製造廠": [
        {
            "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠",
            "製造廠廠址": "台南市新市區中山路182號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808000100",
            "成分名稱": "ACETAMINOPHEN (EQ TO PARACETAMOL)",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡紅紫",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "01014755.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014755&Seq=065&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "LD03-中文品名.申請商變更-111-05-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014755&Seq=005&Type=9"
        },
        {
            "title": "040147550001-104-05-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014755&Seq=004&Type=9"
        },
        {
            "title": "LD03(外銷)-罐裝-104-10-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014755&Seq=004&Type=8"
        }
    ]
}